334 related articles for article (PubMed ID: 30468131)
21. Pharmacoinformatics-based identification of potential bioactive compounds against Ebola virus protein VP24.
Kwofie SK; Broni E; Teye J; Quansah E; Issah I; Wilson MD; Miller WA; Tiburu EK; Bonney JHK
Comput Biol Med; 2019 Oct; 113():103414. PubMed ID: 31536833
[TBL] [Abstract][Full Text] [Related]
22. Topoisomerase II Inhibitors Induce DNA Damage-Dependent Interferon Responses Circumventing Ebola Virus Immune Evasion.
Luthra P; Aguirre S; Yen BC; Pietzsch CA; Sanchez-Aparicio MT; Tigabu B; Morlock LK; García-Sastre A; Leung DW; Williams NS; Fernandez-Sesma A; Bukreyev A; Basler CF
mBio; 2017 Apr; 8(2):. PubMed ID: 28377530
[TBL] [Abstract][Full Text] [Related]
23. Filovirus VP24 Proteins Differentially Regulate RIG-I and MDA5-Dependent Type I and III Interferon Promoter Activation.
He FB; Khan H; Huttunen M; Kolehmainen P; Melén K; Maljanen S; Qu M; Jiang M; Kakkola L; Julkunen I
Front Immunol; 2021; 12():694105. PubMed ID: 35069519
[TBL] [Abstract][Full Text] [Related]
24. Ebolavirus VP35 suppresses IFN production from conventional but not plasmacytoid dendritic cells.
Leung LW; Park MS; Martinez O; Valmas C; López CB; Basler CF
Immunol Cell Biol; 2011 Oct; 89(7):792-802. PubMed ID: 21263462
[TBL] [Abstract][Full Text] [Related]
25. Ebola virus VP24 binds karyopherin alpha1 and blocks STAT1 nuclear accumulation.
Reid SP; Leung LW; Hartman AL; Martinez O; Shaw ML; Carbonnelle C; Volchkov VE; Nichol ST; Basler CF
J Virol; 2006 Jun; 80(11):5156-67. PubMed ID: 16698996
[TBL] [Abstract][Full Text] [Related]
26. The Integrity of the YxxL Motif of Ebola Virus VP24 Is Important for the Transport of Nucleocapsid-Like Structures and for the Regulation of Viral RNA Synthesis.
Takamatsu Y; Kolesnikova L; Schauflinger M; Noda T; Becker S
J Virol; 2020 Apr; 94(9):. PubMed ID: 32102881
[TBL] [Abstract][Full Text] [Related]
27. Identification of Myricetin as an Ebola Virus VP35-Double-Stranded RNA Interaction Inhibitor through a Novel Fluorescence-Based Assay.
Daino GL; Frau A; Sanna C; Rigano D; Distinto S; Madau V; Esposito F; Fanunza E; Bianco G; Taglialatela-Scafati O; Zinzula L; Maccioni E; Corona A; Tramontano E
Biochemistry; 2018 Nov; 57(44):6367-6378. PubMed ID: 30298725
[TBL] [Abstract][Full Text] [Related]
28. Ebola virus replication is regulated by the phosphorylation of viral protein VP35.
Zhu L; Gao T; Yang W; Liu Y; Liu X; Hu Y; Jin Y; Li P; Xu K; Zou G; Zhao L; Cao R; Zhong W; Xia X; Cao C
Biochem Biophys Res Commun; 2020 Jan; 521(3):687-692. PubMed ID: 31694758
[TBL] [Abstract][Full Text] [Related]
29. Tetherin Inhibits Nipah Virus but Not Ebola Virus Replication in Fruit Bat Cells.
Hoffmann M; Nehlmeier I; Brinkmann C; Krähling V; Behner L; Moldenhauer AS; Krüger N; Nehls J; Schindler M; Hoenen T; Maisner A; Becker S; Pöhlmann S
J Virol; 2019 Feb; 93(3):. PubMed ID: 30429347
[TBL] [Abstract][Full Text] [Related]
30. Development of RNA aptamers targeting Ebola virus VP35.
Binning JM; Wang T; Luthra P; Shabman RS; Borek DM; Liu G; Xu W; Leung DW; Basler CF; Amarasinghe GK
Biochemistry; 2013 Nov; 52(47):8406-19. PubMed ID: 24067086
[TBL] [Abstract][Full Text] [Related]
31. A single phosphorodiamidate morpholino oligomer targeting VP24 protects rhesus monkeys against lethal Ebola virus infection.
Warren TK; Whitehouse CA; Wells J; Welch L; Heald AE; Charleston JS; Sazani P; Reid SP; Iversen PL; Bavari S
mBio; 2015 Feb; 6(1):. PubMed ID: 25670780
[TBL] [Abstract][Full Text] [Related]
32. Integrated Computational Approach for Virtual Hit Identification against Ebola Viral Proteins VP35 and VP40.
Mirza MU; Ikram N
Int J Mol Sci; 2016 Oct; 17(11):. PubMed ID: 27792169
[TBL] [Abstract][Full Text] [Related]
33. Expression of the Ebola Virus VP24 Protein Compromises the Integrity of the Nuclear Envelope and Induces a Laminopathy-Like Cellular Phenotype.
Vidal S; Sánchez-Aparicio M; Seoane R; El Motiam A; Nelson EV; Bouzaher YH; Baz-Martínez M; García-Dorival I; Gonzalo S; Vázquez E; Vidal A; Muñoz-Fontela C; García-Sastre A; Rivas C
mBio; 2021 Aug; 12(4):e0097221. PubMed ID: 34225493
[TBL] [Abstract][Full Text] [Related]
34. Ebola virus: A gap in drug design and discovery - experimental and computational perspective.
Balmith M; Faya M; Soliman ME
Chem Biol Drug Des; 2017 Mar; 89(3):297-308. PubMed ID: 27637475
[TBL] [Abstract][Full Text] [Related]
35. Intracellular human antibody fragments recognizing the VP35 protein of Zaire Ebola filovirus inhibit the protein activity.
Flego M; Frau A; Accardi L; Mallano A; Ascione A; Gellini M; Fanunza E; Vella S; Di Bonito P; Tramontano E
BMC Biotechnol; 2019 Sep; 19(1):64. PubMed ID: 31488108
[TBL] [Abstract][Full Text] [Related]
36. Structure of the Ebola VP35 interferon inhibitory domain.
Leung DW; Ginder ND; Fulton DB; Nix J; Basler CF; Honzatko RB; Amarasinghe GK
Proc Natl Acad Sci U S A; 2009 Jan; 106(2):411-6. PubMed ID: 19122151
[TBL] [Abstract][Full Text] [Related]
37. A Luciferase Reporter Gene Assay to Measure Ebola Virus Viral Protein 35-Associated Inhibition of Double-Stranded RNA-Stimulated, Retinoic Acid-Inducible Gene 1-Mediated Induction of Interferon β.
Cannas V; Daino GL; Corona A; Esposito F; Tramontano E
J Infect Dis; 2015 Oct; 212 Suppl 2():S277-81. PubMed ID: 25926684
[TBL] [Abstract][Full Text] [Related]
38. Mutations abrogating VP35 interaction with double-stranded RNA render Ebola virus avirulent in guinea pigs.
Prins KC; Delpeut S; Leung DW; Reynard O; Volchkova VA; Reid SP; Ramanan P; Cárdenas WB; Amarasinghe GK; Volchkov VE; Basler CF
J Virol; 2010 Mar; 84(6):3004-15. PubMed ID: 20071589
[TBL] [Abstract][Full Text] [Related]
39. Filoviral immune evasion mechanisms.
Ramanan P; Shabman RS; Brown CS; Amarasinghe GK; Basler CF; Leung DW
Viruses; 2011 Sep; 3(9):1634-49. PubMed ID: 21994800
[TBL] [Abstract][Full Text] [Related]
40. Analysis of CD8
Sakabe S; Sullivan BM; Hartnett JN; Robles-Sikisaka R; Gangavarapu K; Cubitt B; Ware BC; Kotliar D; Branco LM; Goba A; Momoh M; Sandi JD; Kanneh L; Grant DS; Garry RF; Andersen KG; de la Torre JC; Sabeti PC; Schieffelin JS; Oldstone MBA
Proc Natl Acad Sci U S A; 2018 Aug; 115(32):E7578-E7586. PubMed ID: 30038008
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]